Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Dow
Healthtrust
Cantor Fitzgerald
Chinese Patent Office
QuintilesIMS
Medtronic
Harvard Business School
Novartis
Cerilliant

Generated: January 18, 2018

DrugPatentWatch Database Preview

ISOSORBIDE MONONITRATE Drug Profile

« Back to Dashboard

Which patents cover Isosorbide Mononitrate, and when can generic versions of Isosorbide Mononitrate launch?

Isosorbide Mononitrate is a drug marketed by Accord Hlthcare, Actavis Elizabeth, Alkermes Gainesville, Dexcel Ltd, Hikma Pharms, Ivax Sub Teva Pharms, Kremers Urban Pharms, Nesher Pharms, Skyepharma Ag, Torrent Pharms, Vintage Pharms, and Ani Pharms Inc. and is included in fifteen NDAs.

The generic ingredient in ISOSORBIDE MONONITRATE is isosorbide mononitrate. There are thirty-seven drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the isosorbide mononitrate profile page.
Drug patent expirations by year for ISOSORBIDE MONONITRATE
Pharmacology for ISOSORBIDE MONONITRATE
Ingredient-typeNitrates
Drug ClassNitrate Vasodilator
Physiological EffectVasodilation

US Patents and Regulatory Information for ISOSORBIDE MONONITRATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Elizabeth ISOSORBIDE MONONITRATE isosorbide mononitrate TABLET;ORAL 075037-001 Oct 30, 1998 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ani Pharms Inc ISOSORBIDE MONONITRATE isosorbide mononitrate TABLET;ORAL 075147-001 Nov 27, 1998 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Accord Hlthcare ISOSORBIDE MONONITRATE isosorbide mononitrate TABLET, EXTENDED RELEASE;ORAL 209684-001 Oct 24, 2017 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Nesher Pharms ISOSORBIDE MONONITRATE isosorbide mononitrate TABLET, EXTENDED RELEASE;ORAL 075395-002 Mar 16, 2000 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Vintage Pharms ISOSORBIDE MONONITRATE isosorbide mononitrate TABLET, EXTENDED RELEASE;ORAL 090598-001 Aug 11, 2010 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Dexcel Ltd ISOSORBIDE MONONITRATE isosorbide mononitrate TABLET, EXTENDED RELEASE;ORAL 075522-002 Sep 20, 2016 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Actavis Elizabeth ISOSORBIDE MONONITRATE isosorbide mononitrate TABLET, EXTENDED RELEASE;ORAL 075306-001 Dec 31, 1998 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ivax Sub Teva Pharms ISOSORBIDE MONONITRATE isosorbide mononitrate TABLET, EXTENDED RELEASE;ORAL 075448-001 Jun 19, 2000 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Skyepharma Ag ISOSORBIDE MONONITRATE isosorbide mononitrate TABLET, EXTENDED RELEASE;ORAL 075166-001 Oct 7, 1999 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Dexcel Ltd ISOSORBIDE MONONITRATE isosorbide mononitrate TABLET, EXTENDED RELEASE;ORAL 075522-001 Apr 17, 2000 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
Chubb
US Department of Justice
Fish and Richardson
Moodys
Boehringer Ingelheim
Daiichi Sankyo
Medtronic
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot